Mark H. Wilcox
Impact in
- Infectious Diseases top 0.01%
- Clostridium difficile and Clostridium perfringens research
- Viral gastroenteritis research and epidemiology
- Antimicrobial Resistance in Staphylococcus
-
- Nosocomial Infections in ICU
Papers in
-
- Clostridium difficile and Clostridium perfringens research 268
- Antimicrobial Resistance in Staphylococcus 100
- Viral gastroenteritis research and epidemiology 96
-
- Nosocomial Infections in ICU 65
- Co-authors
- Dale N. GerdingEd J. KuijperWarren N. FawleyStuart JohnsonVivian G. LooCiarán P. KellyJane FreemanMaja Rupnik
- Journals
- Journal of Antimicrobial Chemotherapy (58 papers)Journal of Hospital Infection (42 papers)Clinical Infectious Diseases (25 papers)Journal of Clinical Microbiology (20 papers)Clinical Microbiology and Infection (18 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Mark H. Wilcox
429 papers receiving 27.1k citations
Hit Papers
Peers
Comparison fields: 5 of 196
- Infectious Diseases 22.0k
- Critical Care and Intensive Care Medicine 4.2k
- Applied Microbiology and Biotechnology 1.1k
- Epidemiology 14.1k
- Gastroenterology 2.0k
Countries citing papers authored by Mark H. Wilcox
This map shows the geographic impact of Mark H. Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Wilcox more than expected).
Fields of papers citing papers by Mark H. Wilcox
This network shows the impact of papers produced by Mark H. Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Wilcox. The network helps show where Mark H. Wilcox may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark H. Wilcox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 9 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 26 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 12 | |
| 10 | Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System | 2022 | 3 |
| 11 | 2020 | 8 | |
| 12 | 2020 | 36 | |
| 13 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Hit paper breakdown → | 2017 | 1891 |
| 14 | 2017 | 19 | |
| 15 | 2014 | 25 | |
| 16 | 2012 | 157 | |
| 17 | 2009 | 1 | |
| 18 | 2008 | 21 | |
| 19 | 2008 | 47 | |
| 20 | 2004 | 8 |
About Mark H. Wilcox
Mark H. Wilcox is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry and Epidemiology, having authored 439 papers that have together received 27.9k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (268 papers), Microscopic Colitis (166 papers), Antimicrobial Resistance in Staphylococcus (100 papers), Viral gastroenteritis research and epidemiology (96 papers), Nosocomial Infections in ICU (65 papers), Bacterial Identification and Susceptibility Testing (55 papers), Gut microbiota and health (43 papers) and Helicobacter pylori-related gastroenterology studies (42 papers). The work is most often cited by research in Infectious Diseases (22.0k citations), Critical Care and Intensive Care Medicine (4.2k citations), Applied Microbiology and Biotechnology (1.1k citations), Epidemiology (14.1k citations) and Gastroenterology (2.0k citations). Mark H. Wilcox has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Dale N. Gerding, Ed J. Kuijper, Warren N. Fawley, Stuart Johnson, Vivian G. Loo, Ciarán P. Kelly, Jane Freeman, Maja Rupnik, L. Clifford McDonald and Simon D. Baines. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Clinical Infectious Diseases, Journal of Clinical Microbiology and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.